These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Stevens-Johnson syndrome and toxic epidermal necrolysis-challenges of recognition and management. Sane SP; Bhatt AD J Assoc Physicians India; 2000 Oct; 48(10):999-1003. PubMed ID: 11200928 [TBL] [Abstract][Full Text] [Related]
3. Burn Center Care of Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Cartotto R Clin Plast Surg; 2017 Jul; 44(3):583-595. PubMed ID: 28576247 [TBL] [Abstract][Full Text] [Related]
4. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report. Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493 [TBL] [Abstract][Full Text] [Related]
5. Toxic epidermal necrolysis and Stevens-Johnson syndrome: a review. Gerull R; Nelle M; Schaible T Crit Care Med; 2011 Jun; 39(6):1521-32. PubMed ID: 21358399 [TBL] [Abstract][Full Text] [Related]
6. [News in severe clinical adverse drug reactions: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)]. Martínez-Cabriales SA; Gómez-Flores M; Ocampo-Candiani J Gac Med Mex; 2015; 151(6):777-87. PubMed ID: 26581536 [TBL] [Abstract][Full Text] [Related]
9. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors. La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941 [TBL] [Abstract][Full Text] [Related]
10. Toxic epidermal necrolysis: 10 years experience of a burns centre in Hong Kong. Ying S; Ho W; Chan HH Burns; 2001 Jun; 27(4):372-5. PubMed ID: 11348746 [TBL] [Abstract][Full Text] [Related]
11. [Stevens-Johnson syndrome and toxic epidermal necrolysis; therapy policy in these life-threatening illnesses. Netherlands Work Group Toxic Epidermal Necrolysis]. van der Meer JB Ned Tijdschr Geneeskd; 1996 Jul; 140(30):1538-43. PubMed ID: 8765761 [No Abstract] [Full Text] [Related]
12. Toxic epidermal necrolysis and Stevens-Johnson syndrome: things we should know! Kamolz LP; Spendel S; Prandl EC Crit Care Med; 2011 Jun; 39(6):1600-1. PubMed ID: 21610649 [No Abstract] [Full Text] [Related]
13. Toxic epidermal necrolysis syndrome--management and case report. Najem JC; Raphael N; Ghanime G; Karam R; Tohme H; Moukarzel Z; Achy J Middle East J Anaesthesiol; 2004 Oct; 17(6):1079-91. PubMed ID: 15651515 [TBL] [Abstract][Full Text] [Related]
14. Toxic epidermal necrolysis and Stevens-Johnson syndrome: soluble Fas ligand involvement in the pathomechanisms of these diseases. Abe R J Dermatol Sci; 2008 Dec; 52(3):151-9. PubMed ID: 18657400 [TBL] [Abstract][Full Text] [Related]
15. European Dermatology Forum: skin diseases in Europe. Skin diseases with a high public health impact: toxic epidermal necrolysis and Stevens-Johnson syndrome. Fritsch P Eur J Dermatol; 2008; 18(2):216-7. PubMed ID: 18424404 [No Abstract] [Full Text] [Related]
16. [Advancement in the diagnosis and management of toxic epidermal necrolysis]. Sun W; Min D; Guo G Zhonghua Shao Shang Za Zhi; 2016 Jun; 32(6):341-4. PubMed ID: 27321487 [TBL] [Abstract][Full Text] [Related]
20. Rapid immunochromatographic test for serum granulysin is useful for the prediction of Stevens-Johnson syndrome and toxic epidermal necrolysis. Fujita Y; Yoshioka N; Abe R; Murata J; Hoshina D; Mae H; Shimizu H J Am Acad Dermatol; 2011 Jul; 65(1):65-8. PubMed ID: 21507517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]